MiR-15a expression has been found to be upregulated in liver cancer tissues associated with hepatitis B. Smad 7, which blocks TGF-β signaling, is a target of miR-15a in these tissues, leading to the suppression of cell growth92. Here, TGFB1 is linked to hepatitis B virus infection.